KERYX BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 492515901.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $43,000 | -35.8% | 129 | -28.3% | 0.00% | – |
| Q2 2018 | $67,000 | +644.4% | 180 | -24.1% | 0.00% | – |
| Q1 2018 | $9,000 | -70.0% | 237 | -56.7% | 0.00% | -100.0% |
| Q4 2017 | $30,000 | -77.6% | 547 | -34.8% | 0.00% | -80.0% |
| Q3 2017 | $134,000 | -15.2% | 839 | -6.8% | 0.01% | -28.6% |
| Q2 2017 | $158,000 | +154.8% | 900 | +40.2% | 0.01% | +133.3% |
| Q1 2017 | $62,000 | +87.9% | 642 | +139.6% | 0.00% | +50.0% |
| Q4 2016 | $33,000 | +175.0% | 268 | +34.7% | 0.00% | +100.0% |
| Q3 2016 | $12,000 | +200.0% | 199 | +226.2% | 0.00% | – |
| Q2 2016 | $4,000 | -85.7% | 61 | -58.8% | 0.00% | -100.0% |
| Q1 2016 | $28,000 | +55.6% | 148 | -52.4% | 0.00% | +100.0% |
| Q4 2015 | $18,000 | +1700.0% | 311 | +111.6% | 0.00% | – |
| Q3 2015 | $1,000 | -92.3% | 147 | +12.2% | 0.00% | -100.0% |
| Q2 2015 | $13,000 | – | 131 | +555.0% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 20 | -85.6% | 0.00% | -100.0% |
| Q4 2014 | $21,000 | – | 139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 79,800 | $373,000 | 0.01% |
| SIMPLEX TRADING, LLC | 148 | $28,000 | 0.00% |
| Citadel Advisors | 88,400 | $413,000 | 0.00% |